• About us
• Contact

Advertisement

Organisation › Details

Sartorius Stedim BioOutsource Ltd.

BioOutsource provides contract testing services to the biopharmaceutical industry. Our core offering includes a comprehensive range of services to support the testing of Biologics, Vaccines & Biosimilars throughout their development. We possess an unparalleled combination of commercial, regulatory and technical knowledge that enables us to truly stand out as the industry's increasingly preferred testing partner. We understand the importance of our service to support our client's critical testing requirements and as a result, continually strive to provide a world class service globally. *

 

Contact: information@biooutsource.com

Profile: Global contract testing organisation offering a comprehensive range of testing solutions for the pharmaceutical and biopharmaceutical industries.

Industry: Contract Testing Organisation (CTO/CRO)

Products/Services: Range of testing services to support the following products throughout development and manufacturing: biosimilars, monoclonal antibodies, virus & vectors, recombinant proteins, antibody-drug conjugates and regenerative medicine.

Established: 2007

Employees: 80 full time employees


The organisation submitted the information to [LSE] on 5 June 2014.

	Start	2007-08-01 established
	Group	Sartorius (Group)
	Predecessor	BioOutsource Ltd.
	Industry	laboratory services
	Industry 2	DRUGS, BIOGEN, GENERICS (biosimilars / biogenerics)
	Person	MacKay, Gerry (Refeyn 202401– CEO before Sartorius + Millipore + BioOutsource)
	Region	Glasgow
	Country	United Kingdom (GB)
	Street	1 Technology Terrace, Todd Campus West of Scotland Science Park
	City	G20 0XA Glasgow, Scotland
	Tel	+44-141-946-4222
		Address record changed: 2020-12-02
Basic data	Employees	C: 51 to 100 (2014-12-31)
		* Document for »About Section«:
		Record changed: 2025-03-16

Advertisement

More documents for Sartorius (Group)

• [1] Sartorius Stedim Biotech. (4/23/26). "Press Release: Sartorius Stedim Biotech Reports Robust First-quarter Results for Fiscal 2026". Aubagne....
• [2] Sartorius AG. (4/23/26). "Press Release: Sartorius Marks PositiveStart to 2026 – Considerable Sales Revenue Growth and Resilient Profit Margin". Göttingen....
• [3] Sartorius AG. (12/6/24). "Press Release: Michael Grosse to Succeed Joachim Kreuzburg as Chief Executive Officer of Sartorius AG". Göttingen....
• [4] Sartorius AG. (7/2/24). "Press Release: Sartorius AG – After more than 20 Years as CEO, Joachim Kreuzburg Will Not Pursue another Term in Office – Supervisory Board Expresses Great Regret". Göttingen....
• [5] Lumicks Technologies B.V.. (5/29/24). "Press Release: Lumicks Appoints Hugo de Wit as CEO and Executive Board Director". Amsterdam....
• [6] Refeyn Ltd.. (5/22/24). "Press Release: Refeyn Announces Appointment of Fiona Coats as Chief Marketing Officer". Oxford....
• [7] Sartorius AG. (5/16/24). "Press Release: Sartorius to Advance Drug Discovery and Manufacturing with AI in Collaboration with Nvidia". Göttingen....
• [8] Sartorius AG. (5/13/24). "Press Release: Sartorius Collaborates with Sanofi to Commercialize End-to-end Platform for Downstream process intensification". Göttingen....
• [9] Refeyn Ltd.. (10/2/23). "Press Release: Refeyn Announces Appointment of New CEO". Oxford....
• [10] Sartorius AG. (9/28/23). "Press Release: Sartorius Forms Partnership with Sparta Biodiscovery on Novel Nanoparticle Analysis Platform". Göttingen....

To subscribe to our free, monthly mass spectrometry newsletter, please send an e-mail to info@iito.de and simply fill the subject line with the word »MSC Newsletter«

Find more infos about advertising at [iito] web portals in our media flyer [iito] in a Nutshell [PDF file]

Please visit also our web portals for the Eurpean life sciences and the life sciences in German-speaking Europe (DE, AT & CH) at Life-Sciences-Germany.com and Life-Sciences-Europe.com

Advertisement

» top

» Imprint  |  » Data Privacy  |  » Contact  |  The use of this website requires to accept the » Disclaimer!   |  A project of [iito] Business Intelligence © 2002-2026. Made in Germany.